Lv6
2050 积分 2021-04-26 加入
Modulating the BI ‐1( TMBIM6 )/ AKT Signaling Pathway by Licochalcone D Treatment Inhibits Human Melanoma Cell Growth
1个月前
已完结
Targeting PI3K in cancer: mechanisms and advances in clinical trials
1个月前
已完结
TMBIM6/BI-1 contributes to cancer progression through assembly with mTORC2 and AKT activation
1个月前
已完结
Recent advances of the mechanistic target of rapamycin (mTOR) inhibitors for drug discovery
2个月前
已完结
Targeting mTOR Kinase for Cancer Treatment: A Comprehensive Review With Clinical Insights
2个月前
已完结
TMBIM6/BI-1 is an intracellular environmental regulator that induces paraptosis in cancer via ROS and Calcium-activated ERAD II pathways
2个月前
已完结
Breast Cancer: Molecular Pathogenesis and Targeted Therapy
2个月前
已完结
Liposomal delivery of DK14 chalcone analogue: A promising therapeutic strategy against triple-negative breast cancer
2个月前
已完结
The PI3K/Akt/mTOR Signaling Pathway in Triple-Negative Breast Cancer: A Resistance Pathway and a Prime Target for Targeted Therapies
2个月前
已完结
Strategic advancements in targeting the PI3K/AKT/mTOR pathway for Breast cancer therapy
2个月前
已完结
皖公网安备34019202002308
